Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 2005

Hepatitis C virus associated arthritis in absence of clinical, biochemical and histological evidence of liver disease - responding to interferon therapy. In reply Leter to the Editor

Shigemasa Sawada

Med Sci Monit 2005; 11(9): LE10-10 :: ID: 428460


Dear Editor, It is my great pleasure to read Newsletter of Medical ScienceMonitor Publication which is the July 2005 issue. Especially, I was most impressed an article subscribedby Akhtar AJ and Funnye AS entitled 'Hepatitis C virus associated arthritis in absence of clinical, biochemicaland histological evidence of liver disease-responding to interferon therapy' [1]. They reported thatseronegative and non erosive polyarthritis with hepatitis C type 1b, having very high viral load, wasimproved by the interferon therapy. This report strongly suggests that the cause of chronic arthritisis due to virus probable hepatitis C virus in some arthritis patient, and encourages us who investigateon the viral etiology for chronic arthritis. As author described, a comprehensive evaluation, includingMRI joint examination, synovial fluid PCR studies, the HCV-RNA in situ hybridization studies and HCVrelated protein studies of synovial cells will help to reveal the etiology for this arthritis. Nontherless,it is curious that a liver biopsy revealed normal liver histology, without evidence of inflammation.But this is suggesting that this virus may have a different RNA sequences, comparing with usual hepatitisC virus and may infect and proliferate in the synovial tissue which is very unusual but this might beas an alternative idea. Another event, this patient's immune system should be remained as investigation.The evidences for the relation with virus and arthritis are accumulating. Especially, Parvovirus B 19[2] and Epstein Barr virus are strong candidate for rheumatoid arthritis etiology. Epstein-Barr virus(EBV) has been a strong candidate about for over 25 years as environmental infectious agent(s). Thereare many circumstantial evidence for association between EBV and RA, but definite evidence is wanting.We reviewed an increase circumstantial proof which has been investigated so far and demonstrate directevidence for the presence of EBV in inflamed synovial cells in patients with RA and abnormal evidenceson the recent finding of signaling lymphocytic-activation molecule (SLAM)-associated protein (SAP), whichopened a new approach to understand on impaired function of cytotoxic T cell for EBV in patients withRA [3].We have several experience which arthritis activity was improved by the Aciclovir for Herpes Zosterin patients with rheumatoid arthritis. This means that some patients from rheumatoid arthritis are stronglyassociated with Herpes group virus as well as Akhtar AJ's arthritis patient is also strongly associatedwith hepatitis C virus because of an improvement by the interferon therapy. Eventhogh, Akhtar AJ's paientis seronegative, this may become seropositive in the future. Murai et al reported that Sixty seven casesshowing acute inflammatory polyarthritis from January 1990 to June 1990 were examined and followed upfor six years. Among them, 12 (9 female and 3 male) exhibited IgM anti-B19 antibodies. PCR, followedby a Southern blot analysis also showed the presence of B19 DNA in all 12 cases with IgM anti-B19 antibodies,but did not in the remainder. Initially, rheumatoid factor (RF) was negative in all B19 positive casesexcept one, but became positive in four, two to four months after the infection. We are learning nowthat Infliximab (Remicade) and etanercept (Enbrel): causes the serious infections and tuberculosis. Thereason why on the serious infection by anti cytokine therapy for arthritis is due to a very severe immunesuppression. The investigation on the etiology for chronic arthritis may establish an ideal therapy withoutside effect. References: 1.Abbasi J, Akhtar, Allen S, Funnyé AS: Hepatitis C virus associated arthritisin absence of clinical, biochemical and histological evidence of liver disease - responding to interferontherapy. Med Sci Monit, 2005; 11(7): CS37-CS39 2.Murai C et al: Rheumatoid arthritis after human parvovirusB19 infection. Ann Rheum Dis, 1999; 58(2): 130-32 3.Sawada S, Takei M: Epstein-Barr virus etiology inrheumatiod arthritis. Autoimmun Rev, 2005; 4(2): 106-10.

Keywords: Antiviral Agents - therapeutic use, Arthritis, Infectious - etiology, Hepatitis C - drug therapy, Interferon Type I - therapeutic use, RNA, Viral - isolation & purification, Recombinant Proteins

Add Comment 0 Comments


01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Database Analysis  

Long-Term Prognosis of Patients Undergoing Percutaneous Coronary Intervention: The Impact of Serum Creatini...

Med Sci Monit In Press; DOI: 10.12659/MSM.943063  

Database Analysis  

Maternal Exposure to Environmental Air Pollution and Premature Rupture of Membranes: Evidence from Southern...

Med Sci Monit In Press; DOI: 10.12659/MSM.943601  

Animal Research  

Enhanced Bone Healing Through Systemic Capsaicin Administration: An Experimental Study on Wistar Rats

Med Sci Monit In Press; DOI: 10.12659/MSM.942485  

Clinical Research  

Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944052  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750